Skip to main content

Cure for TB

Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis

This research appears on 'Journal of Inorganic Biochemistry'

 A team of researchers from Spain and Latin America     have synthesized two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Due their low level of toxicity in mammal cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants.

A group of researchers from the Universidad de Navarra (Spain), the Universidad de la RepĂşblica (Uruguay), the Universidad de SĂŁo Paulo (Brazil) and the Universidad Nacional de La Plata (Argentina) have synthesized two iron complexes "that showed in vitro growth inhibitory activity on Mycobacterium tuberculosis", Dinorah Gambino and MarĂ­a Torre, authors of the study and researchers at the Universidad de la RepĂşblica explained to SINC.

The study, published this month by the Journal of Inorganic Biochemistry uses iron atoms to join organic molecules (derived from quinoxaline ), forming compounds that act as bactericides (killing bacteria) or bacteriostatic agents (preventing bacteria from reproducing). The organic molecules were synthesized at the Universidad de Navarra.

"One of the greatest problems in relation to the pharmacotherapy for treating tuberculosis is the appearance of bacteria resistant to current medicines, which is why it is important to develop new active ingredients", the researchers indicate.

In order to treat tuberculosis, initially "first-line" antibiotics are used (such as isoniacide or estreptomicine ), but when side effects appear, or in cases of stronger resistance, "second-line" antibiotics are resorted to (such as cicloserine or ciprofloxacine ). The new compounds inhibit M. tuberculosis better than the "second-line" medicines.

Low Toxicity

Another advantage of the iron compounds is that they show low toxicity in mammel cells, as demonstrated by the experiments performed with mice cells. "That is why these compounds are useful as hospital disinfectants or therapeutic agents," the Uruguayan researchers highlight, albeit recalling that, at present, they in vitro trials "and the line of research remains open to learn more about how they act."

Antonio Monge, co-author of the study and a researcher at the Universidad de Navarra, underlines the importance of cooperating with research centres in Latin America, where there are many cases of tuberculosis and other diseases such as malaria or chagas disease. "This type of cooperation always benefits the person who is suffering".

Tuberculosis kills more than one million people a year worldwide (1.3 million in 2008). Various Mycobacterium species - particularly M. tuberculosis- are the cause.

At present, tuberculosis is considered a re-emerging disease due to the increase in the number of people with HIV and other viruses that attack the immune system, as well as to the increasing consumption of immunosuppressive and recreational drugs. The World Health Organization (WHO) estimates that 30 million people will be infected by tuberculosis over the next 20 years.

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...

Permitted non-hormonal performance-enhancing substances

What? Performance enhancers? For decades athletes and non-athletes have been using performance-enhancing drugs/supplements> However most of the time the news  flash comes when a competitive athlete is caught using banned hormonal & non-hormonal substances. They can be broadly classified as: Stimulants Prescription medications Blood buffers Nutritional supplements Energy beverages STIMULANTS They are both physical and cognitive performance enhancers.  Beneficial effects include increase in: Energy level,  Endurance,  Anaerobic performance, r Reaction time,  Concentration, and alertness.  Adverse effects include Headache,  Nausea,  Insomnia,  Anxiety,  Tremor,  Agitation,  Panic attacks,  Hypertension, and tachycardia.  Rarely, stimulants may cause myocardial ischemia, stroke, psychosis, heatstroke, or rhabdomyolysis. While many stimulants (eg, methylhexana...